Bone Biologics Balance Sheet Health
Financial Health criteria checks 4/6
Bone Biologics has a total shareholder equity of $3.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.1M and $273.4K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.57m |
| Equity | US$3.79m |
| Total liabilities | US$273.40k |
| Total assets | US$4.07m |
Financial Position Analysis
Short Term Liabilities: BBLG's short term assets ($4.1M) exceed its short term liabilities ($273.4K).
Long Term Liabilities: BBLG has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BBLG is debt free.
Reducing Debt: BBLG currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BBLG has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BBLG has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19.7% each year